Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07344974Phase 4Not yet recruiting
A Phase 4 trial of Yi-Qi Yang-Xue Tong-Luo Fang in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Peking University Cancer Hospital & Institute. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07344974.